Introduction
Anandamide is an endogenous derivative of arachidonic acid that binds with high affinity to cannabinoid receptors and mimics virtually all pharmacological actions of plant-Ž derived or synthetic cannabinoid drugs Devane et al., . 1992 . Anandamide may be produced physiologically through enzymatic cleavage of the phospholipid precursor, Ž N-arachidonyl-phosphatidylethanolamine Di Marzo et al., 1994; Cadas et al., 1996; Sugiura et al., 1996; Cadas et al., . 1997 , a reaction that may be triggered by the stimulation Ž of neurotransmitter receptors Di Marzo et al., 1994; Giuf-. frida et al., 1999 . After release, anandamide is disposed of ) Corresponding author. Tel.: q1-949-824-4377; fax: q1-949-824-6305.
Ž . E-mail address: agiuffri@uci.edu A. Giuffrida . 1 On leave of absence from the Department of Neuroscience, University of Cagliari, 09124 Cagliari, Italy. through a rapid inactivation process consisting of uptake Ž . into cells Beltramo et al., 1997; Hillard et al., 1997 Ž followed by catalytic hydrolysis Desarnaud et al., 1995;  . Ueda et al., 1995; Cravatt et al., 1996 . Anandamide uptake is a Na q -independent process that fulfills four key criteria that define carried-mediated transport: high affinity, temperature dependence, substrate selectivity and sub-Ž strate saturation Beltramo et al., 1997; Hillard et al., . 1997 . Moreover, anandamide transport may be pharmacologically inhibited by several compounds, including brom-Ž . cresol green and N-4-hydroxyphenyl arachidonylamide Ž .Ž . AM404 Beltramo et al., 1997; Hillard et al., 1997 . The ability of AM404 to block anandamide transport has been demonstrated in vitro by using rat brain neurons in primary Ž . culture Beltramo et al., 1997 , human astrocytoma cells Ž . Ž Piomelli et al., 1999 , and rat brain slices Beltramo et al., . 2000 . Furthermore, in vivo experiments have shown that AM404 increases and prolongs several pharmacological Ž responses elicited by exogenous anandamide e.g., analgesia Beltramo et al., 1997 and hypotension Calignano et al., 0014-2999r00r$ -see front matter q 2000 Elsevier Science B.V. All rights reserved.
Ž . PII: S 0 0 1 4 -2 9 9 9 0 0 0 0 7 8 6 -X ( ) . 1997a . Despite its structural similarities with anandamide, AM404 does not appear to produce a complete spectrum of cannabimimetic responses when administered alone. For example, AM404 does not elicit significant catalepsy or Ž . analgesia in rats Beltramo et al., 2000 and hypotension in Ž . guinea pigs Calignano et al., 1997a , three pharmacologi-Ž cal hallmarks of direct-acting cannabinoid agonists Per-. twee, 1997 . This lack of overt cannabimimetic activity is consistent with the low affinity of AM404 for cannabinoid Ž CB receptors Beltramo et al., 1997; Beltramo et al., 1 .
2000 . Although AM404 does not appear to act as a direct cannabinoid agonist, some of its pharmacological actions may resemble those of anandamide. For example, AM404 exerts significant inhibitory effects on locomotor activity, and alleviates the hyperactivityrstereotypy evoked by the dopamine receptor agonists, quinpirole and apomorphine Ž . Gonzalez et al., 1999; Beltramo et al., 2000 . Thesé effects, which are reversed by the cannabinoid CB re-
mide P hydrochloride SR141716A , have been suggested to result from the ability of AM404 to block anandamide Ž inactivation and cause it to accumulate in tissues Be-. ltramo et al., 2000 . As a test of this hypothesis, in the present study we have determined the effects of systemic administration of AM404 on the circulating levels of anandamide in rats. Our results indicate that AM404 causes a time-dependent increase of peripheral anandamide, which is accompanied by a reduction in locomotor activity. . amine, respectively Giuffrida and Piomelli, 1998 . This reaction results in the quantitative formation of acyletha-Ž nolamides Devane et al., 1992; Giuffrida and Piomelli, . 1998 , which were concentrated to dryness under a stream of N and reconstituted in chloroform at a concentration of 2 20 mM. Acylethanolamide solutions were stored at y208C Ž . until used. Identity and chemical purity ) 98% of the synthesized acylethanolamides were determined by thin-Ž . layer chromatography TLC using chloroformrmetha-Ž . nolr ammonia 85:15:1, volrvol as solvent system, and subsequently by high-performance liquid chromatogra-Ž . phyr mass spectrometry HPLCrMS .
Materials and methods

Chemicals
Collection and preparation of rat plasma
Ž . Blood 2 ml was collected from the heart of male Sprague-Dawley rats anesthetized with methoxyflurane Ž . Schering-Plough, Union, NJ using a syringe filled with 1 Ž ml of Krebs-Tris buffer in mM: NaCl 136, KCl 5, MgCl 2 . 1.2, CaCl 2.5, glucose 10, Trizma base 20; pH 7.4 2 containing 4.5 mM EDTA. Blood samples were drawn at 0, 30, 60, and 120 min after administration of a single dose Ž y1 . of AM404 10 mg kg intraperitoneal, i.p. , and cen-Ž . trifuged in Accuspin tubes Sigma at 800 = g, for 10 min at 228C. After centrifugation, the plasma layers were rew 2 x covered and spiked with 500 pmol of H -labeled 4 acylethanolamides. Plasma proteins were precipitated by Ž . adding cold acetone y208C, 1 vol and removed by centrifugation at 1000 = g for 10 min. The supernatants were flushed with a stream of N to evaporate acetone and 2 subjected to lipid extraction with methanolrchloroform Ž . 1:2, volrvol . The recovered chloroform phases were evaporated to dryness under N , reconstituted in a mixture 2 Ž . of chloroformrmethanol 1:3, 80 ml , and injected into the Ž . HPLCrMS for analysis and quantification see below . The estimated recoveries of anandamide, palmitylethanolamide and oleylethanolamide were 98.7 " 0.2%, 78.1 " 0.8%, and 99.7 " 0.3%, respectively. In parallel experiments, we also measured AM404 levels in plasma by HPLCrMS. However, because of the lack of an appropriate internal standard, the recovery of AM404 was consis-Ž tently lower than that of the acylethanolamides 5.2 " . 0.5%, n s 4 . HP 1100 Series HPLCrMS system equipped Ž . with a Hewlett-Packard octadecylsilica ODS Hypersil Ž . column 100 = 4.6 mm i.d., 5 mm was used. Reversedphase separations were carried out by using linear in-Ž . Ž . Ž creases of methanol B in water A 25% A, 75% B for 2 min; 15% A, 85% B for 3 min; 5% A, 95% B for 20 min;
. 100% B for 5 min at a flow rate of 0.5 mlrmin as Ž . described Giuffrida et al., 2000b . Under these conditions, analytes eluted from the column with the following retention times: anandamide, 15.4 min; palmitylethanolamide, 17.3 min; oleylethanolamide, 18.4 min; AM 404, 15.9 min. MS analyses were performed in the positive ionization mode with an electrospray ion source. Capillary voltage was set at 3.0 kV, and fragmentor voltage was 80 V. Nitrogen was used as drying gas at a flow rate of 12 lrmin. The drying gas temperature was set at 3508C and the nebulizer pressure at 50 psi. For quantitative analyses, diagnostic fragments corresponding to the protonated ( ) Žw
x q . molecules M q H and to the sodium adducts of the Žw x q . molecular ions M q Na were followed in the selected Ž . ion monitoring SIM mode. System control and data evaluation were conducted using an on-line system soft-Ž . ware HP Chemstation . . Siegenthaler, 1990 . The gel was cut into 2-mm bands, Ž which were incubated for 3 h in 0.5-ml Solvable Packard, . Meriden, CT at 508C. Radioactivity was measured by liquid scintillation counting.
BehaÕioral tests
We studied the effects of AM404 10 mg kg , i.p. , Ž vehicle 0.9% saline containing 10% dimethyl sulfoxide, . Ž y1 . i.p. , and AM404 plus SR141716A 0.5 mg kg , i.p. on immobility and horizontal locomotor activity in two groups of male rats, differing in breeding, age and weight. The first group consisted of Wistar rats, 90-106 daysr450-500 Ž . g Charles River Laboratories, Wilmington, MA ; the second group consisted of Sprague-Dawley rats, 56-70 Ž . daysr250-300 g Taconic, Germantown, NY . Motor activity was studied in a Digiscan photocell activity cage Ž . Ž . 42 = 42 = 30 cm Omnitech Electronics, Columbus, OH Ž equipped with 16 photocells eight placed along the X, and . eight along the Y axis of the cage and interfaced to a Ž . microcomputer Digiscan Analyzer that recorded activity automatically. On the experimental day, the animals were Ž placed in the cage, and immobility difference between . sample time and time spent moving and horizontal activ-Ž ity distance traveled by the animal in a given sample . period were recorded at 5-min intervals. This procedure was performed at 5, 30, 60 and 120 min after the injection of either vehicle or drug. SR141716A was injected 30 min before the beginning of the experiment. All behavioral tests were conducted in a sound-isolated room, illuminated Ž . with an indirect halogen light 125 lx .
Data analysis
Results are expressed as means" S.E.M. Statistical significance was evaluated using analysis of variance Ž . ANOVA followed by the Dunnett's test.
Results
Mass spectral properties of AM404
AM404 is a structural analog of anandamide, characterized by a highly hydrophobic carbon chain and a polar Ž carboxamido group carrying a hydroxyphenyl moiety Fig. . 1A . The mass spectral properties of AM404 were investigated by using reversed-phase HPLCrMS in a mobile phase of methanolrwater. Mass spectra were acquired in the positive-ionization mode, because the total ion current Ž . TIC yielded by this ionization procedure was significantly higher than that obtained by negative ionization Ž . data not shown . Fig. 1B shows a representative positiveion electrospray spectrum of AM404. The spectrum consists of two main fragments: the protonated molecule Žw 
Žw
x q fragments are mrz 287.2 M-108 , loss of NH-C H - 
Quantification of AM404 in plasma
AM404 analysis was carried out by monitoring the w x q Ž . Ž M q Na fragment mrz 418.2 in the SIM mode Fig. . 1C . This ion, although slightly less abundant than the w x q M q H fragment, was selected because of its greater resolution from contaminating components present in plasma samples. For quantification purposes, a calibration curve was constructed by injecting into the HPLCrMS increasing amounts of AM404. The areas obtained from the integration of SIM peaks were plotted against the injected amounts. Under these conditions the MS re-Ž 2 . sponses were linear r s 0.93; n s 3 over the range Ž . 0-250 pmol data not shown .
Blood samples were collected by cardiac puncture from Ž . rats killed 30, 60, and 120 min following systemic i.p.
Ž . injection of AM404 10 mgrkg . After acetone precipitation of plasma proteins, lipids were extracted with chloroformrmethanol and analyzed by HPLCrMS. All plasma . pmolrml at 60 min after injection, and declining thereafter. As expected of a hydrophobic molecule, the decline of AM404 in plasma was accompanied by a substantial Ž accumulation of the compound in brain tissue data not . shown .
Quantification of anandamide in plasma
To determine whether the systemic administration of AM404 results in accumulation of endogenously produced anandamide, we measured the plasma levels of anan-Ž y1 damide after a bolus injection of AM404 10 mg kg , . i.p. . In the same samples, we measured the levels of two additional fatty acid ethanolamides, palmitylethanolamide and oleylethanolamide, which do not activate cannabinoid receptors. Quantification was carried out by monitoring the w x q M q Na ions with the following mrz values: for ananw 2 x Ž . damide and H -anandamide, mrz 370.3 Fig. 3A All plasma samples contained lipid components that eluted from the HPLC at the retention times expected for anandamide, palmitylethanolamide and oleylethanolamide Ž . Fig. 3B and data not shown . In samples collected imme-Ž . diately 1 min after AM404 administration, we measured 2.8 " 0.3 pmolrml of anandamide, 11 " 1.4 pmolrml of palmitylethanolamide and 10.3 " 2.1 pmolrml of Ž . Ž . oleylethanolamide n s 12 Fig. 4A,B . These levels are identical to those observed in rats that received no drug Ž . injection Giuffrida et al., 2000b and data not shown . Anandamide levels in plasma increased gradually after AM404 administration, and were significantly different Ž . from controls 60 min 5.5 " 1.4 pmolrml, n s 7 and 120 Ž . min 8.1 " 1.8 pmolrml, n s 7 after injection of the drug Ž . Fig. 4A . By contrast, the plasma levels of palmitylethanolamide were not affected by AM404, while those of oleylethanolamide showed a trend towards accumulation that was statistically different from controls only 120 min Ž . Ž . after injection 19.6 " 3.1 pmolrml Fig. 4B . w 3 x Ž Fig. 5 . PAGE analysis under non-denaturing conditions of rat plasma and bovine serum albumin incubated with H -anandamide A1 and A2,
. w 3 x Ž . respectively or H -AM404 B1 and B2, respectively . 2-mm sections of the gel were cut, and radioactivity was measured by liquid scintillation counting. 
Binding of anandamide and AM404 to plasma proteins
Anandamide and AM404 were detectable in plasma only when proteins were first denatured with cold acetone Ž . data not shown , suggesting that these lipids may be tightly associated to plasma proteins. To test this hypothew 3 x sis, H -labeled anandamide was incubated in plasma or in Ž . a solution containing bovine serum albumin 70 mM , and analyzed by PAGE under non-denaturing conditions. All plasma samples showed a significant radioactive peak that Ž . co-migrated on the gel with albumin Fig. 5A1, A2 . Similar results were obtained after electrophoresis of either plasma or bovine serum albumin solutions incubated with w 3 x Ž . H AM404 Fig. 5B1, B2 .
Effects of AM404 on motor behaÕior
Ž As previously reported Gonzalez et al., 1999; Beltramó . Ž et al., 2000 , systemic administration of AM404 10
. mgrkg, i.p. caused a time-dependent decrease in motor activity, which was measured either as increase of time Ž . spent in total immobility Fig. 6A , or as reduction of Ž . horizontal locomotion Fig. 6B . This effect was statistically significant 30 and 60 min after drug administration. Comparable inhibitory effects on motor behaviors were observed in a second group of animals differing from the Ž . previous in breeding, age and weight Fig. 6 , inset . In the latter group, we also tested the effects of the selective cannabinoid CB receptor antagonist SR141716A. Admin-1 Ž
. istration of SR141716A 0.5 mgrkg, i.p. 60 min before AM404 did not cause any change in basal motor activity Ž . data not shown , but reversed the effects of AM404 on Ž . Ž immobility Fig. 6A , inset and locomotor activity Fig. . 6B, inset .
Discussion
Drugs that interfere with anandamide transport have both theoretical and practical interest. Theoretically, they may help uncover the functions of the endocannabinoid system, which remain largely uncharacterized. Practically, they may find applications in a range of therapeutic areas, such as pain, multiple sclerosis and motor disorders ŽPiomelli et al., 2000; Baker et al., 2000; Giuffrida et al., . 2000a .
AM404-the first synthetic inhibitor of anandamide Ž . uptake Beltramo et al., 1997 - has been shown to poten-Ž tiate many effects elicited by anandamide in vitro Be-. Ž ltramo et al., 1997 and in vivo Beltramo et al., 1997;  . Calignano et al., 1997a . Because of the inability of AM404 Ž to activate cannabinoid receptors Beltramo et al., 1997 Beltramo et al., , . 2000 , the effects of this drug were suggested to result from the elevation of endogenous anandamide levels. However, this hypothesis was solely based on pharmacological evidence and was not supported by direct measurements of endogenous anandamide levels after AM404 administration. In the present study, we show that systemic administration of AM404 causes an increase in the concentration of circulating anandamide. This was accompanied by an elevation of AM404 levels in plasma, which reached a peak value of 123 " 22 pmolrml and remained as high as 70.5 pmolrml for at least 2 h after drug administration. These values are likely to reflect the amount of AM404 bound to plasma proteins. Indeed, we found that both AM404 and anandamide bind to a protein in plasma, which we identified as albumin by non-denaturing PAGE.
( ) The concentrations of AM404 at its sites of action, i.e., at the membranes of cells expressing the putative anandamide transporter, remain at present undetermined.
To further investigate the biochemical effects of AM404 in vivo, we also monitored the plasma levels of palmitylethanolamide and oleylethanolamide, two fatty acylethanolamides that are produced through the same biosynthetic Ž mechanism of anandamide Di Marzo et al., 1994; Cadas . et al., 1997 , but do not serve as substrates for the anan-Ž . damide transporter Piomelli et al. 1999 . AM404 administration did not significantly affect the levels of palmitylethanolamide, but caused a slow increase of circulating oleylethanolamide statistically significant 120 min after AM404 injection. Since oleylethanolamide is not transported by anandamide carrier, a possible interpretation of this result is that AM404 may inhibit an as-yet uncharacterized transporter of oleylethanolamide. Alternatively, oleylethanolamide elevation may result from the interference of AM404 with anandamide amidohydrolase, of which oleylethanolamide represents a substrate. However, administration of the potent anandamide amidohydrolase blocker, Ž . Ž . palmitylsulfonyl fluoride AM374 Gifford et al., 1999 had no effect on circulating anandamide levels, although it significantly increased the levels of oleylethanolamide 30 Ž min after drug application A. Giuffrida, F. Nava, A.
. Makriyannis and D. Piomelli, in preparation . Taken together, these results suggest that blockade of anandamide amidohydrolase activity is unlikely to participate in the elevation of anandamide in plasma, but may cause the accumulation of other fatty acid acylethanolamides.
In parallel with its ability to increase anandamide levels in plasma, AM404 also elicited a time-dependent inhibition of motor activity. The hypokinetic effect of AM404 is reminiscent of that observed after anandamide administra-Ž tion Fride and Mechoulam, 1993; Smith et al., 1994;  . Romero et al., 1995 and was reversed by the cannabinoid CB receptor antagonist SR141716A. This drug prevents 1 Ž several responses of anandamide in rats Calignano et al., . Ž 1998 , mice Beltramo et al., 1997 . Ž . 1997b and guinea pigs Calignano et al., 1997a . However, failure of SR141716A to reverse anandamide actions Ž . was also reported Adams et al., 1998 . The reason for these discrepancies are unresolved, and may be due to differences in species, dosage of the drug and experimental design.
Since the motor inhibition produced by AM404 was achieved at a dose that also caused accumulation of anandamide in peripheral blood, and given the inability of Ž AM404 to activate cannabinoid receptors Beltramo et al., . 1997 Beltramo et al., . , 2000 are consistent with the hypothesis that AM404 produced its behavioral effects by protecting endogenous anandamide from transport-mediated inactivation. Alternatively, the effects of AM404 may be ascribed to its ability to activate vanilloid VR1-type receptors ŽZygmunt et al., 2000; Smart and Jerman, 2000; . Ž . al., 2000 . This possibility is unlikely for two reasons: 1 the effects of AM404 were prevented by the highly selective cannabinoid CB receptor antagonist, SR141716A, 1 which does not interfere with vanilloid VR1 receptor Ž . Ž . function Calignano et al., 2000 ; 2 injection of vanilloid agonists into the brain does not cause hypolocomotion Ž . Mezey et al., 2000 , the primary effect of AM404 ob-Ž served in the present and other studies Beltramo et al., . 2000; Gonzalez et al., 1999 . Although the concentrations reached by anandamide in Ž . plasma approximately 10 nM are insufficient to activate Ž cannabinoid receptors K s 50 nM and 1.6 mM for CB d 1
. Ž . and CB receptor, respectively Pertwee, 1997 , it is 2 reasonable to hypothesize that AM404 may cause anandamide to accumulate in brain tissue to an extent that is sufficient to cause biological effects. This would explain why the motor inhibition elicited by AM404 takes place before significant accumulation of anandamide in plasma is observed. However, the sources of plasma anandamide following AM404 administration are still unknown. Indeed, anandamide production has been demonstrated not only within the central nervous system, but also in periph-Ž eral cells, such as macrophages and platelets Schmid et . al., 1997; Wagner et al., 1997 . Microdialysis studies aimed at measuring anandamide outflow in brain areas involved in motor control after AM404 administration should shed light in this important question.
